These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19391657)

  • 1. Infusion centers: opportunities for financial and personal success.
    Garner RJ
    Arch Pathol Lab Med; 2009 Apr; 133(4):591-6. PubMed ID: 19391657
    [No Abstract]   [Full Text] [Related]  

  • 2. "Why can't we have.?": preparing successful business proposals.
    Strickler J
    Nursing; 2012 Nov; 42(11):52-5. PubMed ID: 23076319
    [No Abstract]   [Full Text] [Related]  

  • 3. Premixed i.v. admixtures for reducing costs and labor time in a home infusion company.
    Petroff BJ
    Am J Health Syst Pharm; 2000 Feb; 57(4):390. PubMed ID: 10714977
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationalizing the use of intravenous therapy in newborns.
    Pillay T; Singh S; Adhikari M
    S Afr Med J; 1999 Dec; 89(12):1240-1. PubMed ID: 10678186
    [No Abstract]   [Full Text] [Related]  

  • 5. Survey of home infusion care in England.
    Loader J; Sewell G; Gammie S
    Am J Health Syst Pharm; 2000 Apr; 57(8):763-6. PubMed ID: 10786264
    [No Abstract]   [Full Text] [Related]  

  • 6. In Vivo and Ex Vivo Microscopy: A Business Plan to Justify the Introduction of Similar Emerging Technologies Into Pathology Practice.
    Wells WA; Harhen MT; Thrall MJ; Shevchuk MM; Tearney GJ; Hariri LP
    Arch Pathol Lab Med; 2019 Mar; 143(3):299-304. PubMed ID: 30525933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of Providing Infusion Therapy for Rheumatoid Arthritis in a Hospital-based Infusion Center Setting.
    Schmier J; Ogden K; Nickman N; Halpern MT; Cifaldi M; Ganguli A; Bao Y; Garg V
    Clin Ther; 2017 Aug; 39(8):1600-1617. PubMed ID: 28716293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The home infusion formula: high tech + high touch = high-quality home care.
    Weaver J; Simmons G; Schofield RL
    Caring; 1995 May; 14(5):52-4, 56. PubMed ID: 10142355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology partnerships that save lives worldwide.
    Kass M
    Arch Pathol Lab Med; 2007 Nov; 131(11):1640. PubMed ID: 17979480
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cost-effectiveness analysis of home administration versus hospital administration of intravenous immunoglobulin].
    Rodríguez M; Procupet A; Heras J
    Med Clin (Barc); 1991 Jan; 96(2):47-51. PubMed ID: 1902540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A private approach to renal care in Wales.
    Davies P
    Health Soc Serv J; 1985 Jun; 95(4954):798-9. PubMed ID: 10272652
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current trends in pathology].
    Szabolcsi I
    Orv Hetil; 2000 Nov; 141(48):2632-4. PubMed ID: 11141963
    [No Abstract]   [Full Text] [Related]  

  • 13. Special report: contract management.
    Hospitals; 1988 Mar; 62(6):62-72, 76-8, 82-92. PubMed ID: 3346005
    [No Abstract]   [Full Text] [Related]  

  • 14. Observation units can improve outcomes, financial performance.
    Finarelli M
    Health Care Strateg Manage; 2003 Aug; 21(8):10-2. PubMed ID: 12942688
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of observation units. American College of Emergency Physicians.
    Ann Emerg Med; 1988 Dec; 17(12):1348-52. PubMed ID: 3195788
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost perspectives for outpatient intravenous antimicrobial therapy.
    Tice AD; Hoaglund PA; Nolet B; McKinnon PS; Mozaffari E
    Pharmacotherapy; 2002 Feb; 22(2 Pt 2):63S-70S. PubMed ID: 11837549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home health care costs: intravenous immunoglobulin home infusion therapy.
    Bielory L; Long GC
    Ann Allergy Asthma Immunol; 1995 Mar; 74(3):265-8. PubMed ID: 7889384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost Savings in Inflammatory Bowel Diseases.
    Giese-Kim N; Wu M; Dehghan M; Sceats LA; Park KT
    Am J Gastroenterol; 2020 Oct; 115(10):1698-1706. PubMed ID: 32701731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The business man and the laboratory: standards guarantee profits.
    Hamer JW
    Malays J Pathol; 1997 Dec; 19(2):99-103. PubMed ID: 10879248
    [No Abstract]   [Full Text] [Related]  

  • 20. Choose your weapon. Picking a product line management system that produces.
    Dumbaugh K; DeMarzi-Jeye D
    Softw Healthc; 1987; 5(2):32-7. PubMed ID: 10281973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.